{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/UNCY/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-14T23:55:52.075Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":4371,"canonical_name":"Unicycive Therapeutics, Inc.","cik":"0001766140","uei":null,"lei":null,"duns":null,"ticker":"UNCY"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":27},"count":27,"timeline":[{"ts":"2026-09-29","kind":"sec.filing","form_type":"8-K","title":"8-K — Unicycive Therapeutics, Inc. — 2026-09-29","url_slug":"/sec/cik-0001766140/8-k/0001213900-26-104314","accession_number":"0001213900-26-104314","importance":35},{"ts":"2026-09-28","kind":"sec.filing","form_type":"8-K","title":"8-K — Unicycive Therapeutics, Inc. — 2026-09-28","url_slug":"/sec/cik-0001766140/8-k/0001213900-26-104076","accession_number":"0001213900-26-104076","importance":35},{"ts":"2026-08-14","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Unicycive Therapeutics, Inc. — 2026-08-14","url_slug":"/sec/cik-0001766140/schedule-13g-a/0001213900-26-090075","accession_number":"0001213900-26-090075","importance":30},{"ts":"2026-08-12","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Unicycive Therapeutics, Inc. — 2026-08-12","url_slug":"/sec/cik-0001766140/10-q/0001213900-26-088013","accession_number":"0001213900-26-088013","importance":45},{"ts":"2026-08-12","kind":"sec.filing","form_type":"8-K","title":"8-K — Unicycive Therapeutics, Inc. — 2026-08-12","url_slug":"/sec/cik-0001766140/8-k/0001213900-26-088061","accession_number":"0001213900-26-088061","importance":35},{"ts":"2026-07-30","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — Unicycive Therapeutics, Inc. — 2026-07-30","url_slug":"/sec/cik-0001766140/schedule-13g/0002012383-26-003117","accession_number":"0002012383-26-003117","importance":55},{"ts":"2026-07-28","kind":"sec.filing","form_type":"4/A","title":"4/A — Unicycive Therapeutics, Inc. — 2026-07-28","url_slug":"/sec/cik-0001766140/4-a/0001213900-26-082273","accession_number":"0001213900-26-082273","importance":30},{"ts":"2026-07-02","kind":"sec.filing","form_type":"8-K","title":"8-K — Unicycive Therapeutics, Inc. — 2026-07-02","url_slug":"/sec/cik-0001766140/8-k/0001213900-26-074678","accession_number":"0001213900-26-074678","importance":35},{"ts":"2026-07-01","kind":"sec.form144","reporter":"Vivo Opportunity Fund Holdings, L.P.","title":"Director","shares":1789916,"usd_value":9450756,"security_title":"Common","approx_sale_date":"2026-06-30","accession_number":"0001178937-26-000032","importance":41.890151296},{"ts":"2026-07-01","kind":"sec.filing","form_type":"144","title":"144 — Unicycive Therapeutics, Inc. — 2026-07-01","url_slug":"/sec/cik-0001766140/144/0001178937-26-000032","accession_number":"0001178937-26-000032","importance":30},{"ts":"2026-06-22","kind":"sec.filing","form_type":"8-K","title":"8-K — Unicycive Therapeutics, Inc. — 2026-06-22","url_slug":"/sec/cik-0001766140/8-k/0001213900-26-070316","accession_number":"0001213900-26-070316","importance":35},{"ts":"2026-06-22","kind":"sec.filing","form_type":"DEFA14A","title":"DEFA14A — Unicycive Therapeutics, Inc. — 2026-06-22","url_slug":"/sec/cik-0001766140/defa14a/0001213900-26-070318","accession_number":"0001213900-26-070318","importance":30},{"ts":"2026-06-15","kind":"sec.filing","form_type":"4/A","title":"4/A — Unicycive Therapeutics, Inc. — 2026-06-15","url_slug":"/sec/cik-0001766140/4-a/0001213900-26-068915","accession_number":"0001213900-26-068915","importance":30},{"ts":"2026-06-15","kind":"sec.filing","form_type":"4/A","title":"4/A — Unicycive Therapeutics, Inc. — 2026-06-15","url_slug":"/sec/cik-0001766140/4-a/0001213900-26-068919","accession_number":"0001213900-26-068919","importance":30},{"ts":"2026-06-15","kind":"sec.filing","form_type":"4/A","title":"4/A — Unicycive Therapeutics, Inc. — 2026-06-15","url_slug":"/sec/cik-0001766140/4-a/0001213900-26-068921","accession_number":"0001213900-26-068921","importance":30},{"ts":"2026-06-15","kind":"sec.filing","form_type":"4/A","title":"4/A — Unicycive Therapeutics, Inc. — 2026-06-15","url_slug":"/sec/cik-0001766140/4-a/0001213900-26-068922","accession_number":"0001213900-26-068922","importance":30},{"ts":"2026-06-15","kind":"sec.filing","form_type":"EFFECT","title":"EFFECT — Unicycive Therapeutics, Inc. — 2026-06-15","url_slug":"/sec/cik-0001766140/effect/9999999995-26-001996","accession_number":"9999999995-26-001996","importance":30},{"ts":"2026-06-11","kind":"sec.filing","form_type":"CORRESP","title":"CORRESP — Unicycive Therapeutics, Inc. — 2026-06-11","url_slug":"/sec/cik-0001766140/corresp/0001213900-26-067967","accession_number":"0001213900-26-067967","importance":30},{"ts":"2026-06-11","kind":"sec.filing","form_type":"UPLOAD","title":"UPLOAD — Unicycive Therapeutics, Inc. — 2026-06-11","url_slug":"/sec/cik-0001766140/upload/0000000000-26-005886","accession_number":"0000000000-26-005886","importance":30},{"ts":"2026-06-05","kind":"sec.filing","form_type":"8-K","title":"8-K — Unicycive Therapeutics, Inc. — 2026-06-05","url_slug":"/sec/cik-0001766140/8-k/0001213900-26-065828","accession_number":"0001213900-26-065828","importance":35},{"ts":"2026-06-05","kind":"sec.filing","form_type":"S-3","title":"S-3 — Unicycive Therapeutics, Inc. — 2026-06-05","url_slug":"/sec/cik-0001766140/s-3/0001213900-26-065819","accession_number":"0001213900-26-065819","importance":30},{"ts":"2026-05-21","kind":"sec.filing","form_type":"4","title":"4 — Unicycive Therapeutics, Inc. — 2026-05-21","url_slug":"/sec/cik-0001766140/4/0001213900-26-060079","accession_number":"0001213900-26-060079","importance":30},{"ts":"2026-05-21","kind":"sec.filing","form_type":"4","title":"4 — Unicycive Therapeutics, Inc. — 2026-05-21","url_slug":"/sec/cik-0001766140/4/0001213900-26-060080","accession_number":"0001213900-26-060080","importance":30},{"ts":"2026-05-20","kind":"sec.filing","form_type":"4","title":"4 — Unicycive Therapeutics, Inc. — 2026-05-20","url_slug":"/sec/cik-0001766140/4/0001213900-26-059558","accession_number":"0001213900-26-059558","importance":30},{"ts":"2026-05-20","kind":"sec.filing","form_type":"4","title":"4 — Unicycive Therapeutics, Inc. — 2026-05-20","url_slug":"/sec/cik-0001766140/4/0001213900-26-059560","accession_number":"0001213900-26-059560","importance":30},{"ts":"2026-05-12","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Unicycive Therapeutics, Inc. — 2026-05-12","url_slug":"/sec/cik-0001766140/10-q/0001213900-26-054708","accession_number":"0001213900-26-054708","importance":45},{"ts":"2026-05-12","kind":"sec.filing","form_type":"8-K","title":"8-K — Unicycive Therapeutics, Inc. — 2026-05-12","url_slug":"/sec/cik-0001766140/8-k/0001213900-26-054736","accession_number":"0001213900-26-054736","importance":35}]}